Intercept Pharmaceuticals, Inc.
Oral preparation of obeticholic acid
Last updated:
Abstract:
The present invention pertains to an oral preparation having exceptional elutability, the oral preparation containing obeticholic acid or a pharmacologically acceptable salt thereof, a water-soluble excipient, a disintegrating agent, and a water-soluble polymer binder, wherein the oral preparation is a quick-release tablet.
Status:
Grant
Type:
Utility
Filling date:
30 Mar 2017
Issue date:
16 Aug 2022